FDA Determines Regulatory Review Period for Wiktor Prime Coronary Stent System Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the Wiktor Prime Coronary Stent System, a medical device, in order to extend its patent protection as required by law.